Chaparral Labs
back to search

protein

RE1-silencing transcription factor

REST
protein:Q13127sfari:2disease:asd

Gene

REST

Organism

Homo sapiens(9606)

Length

1097 aa

Mass

121,872 Da

AI summarysource-grounded · cited inline
claude-haiku-4-5-20251001

REST (RE1-silencing transcription factor) is a transcriptional repressor that binds neuron-restrictive silencer elements (NRSE) to silence neuronal genes in non-neuronal cells (UniProt: Q13127). The 1097-amino acid protein recruits corepressors such as SIN3A and RCOR1 to target promoters, facilitating histone deacetylation and methylation to suppress gene expression. REST also regulates neural-specific alternative splicing through SRRM4 and plays roles in developmental switches affecting NMDA receptor composition and osteoblast differentiation.

REST functions in multiple physiological contexts including maintenance of neural stem cell quiescence, stress response during brain aging, and gene repression following cerebral ischemia (UniProt: Q13127). Beyond neuronal development, the protein regulates gene expression under hypoxic conditions and suppresses SRRM3 in breast cancer. Disease associations include Wilms tumor 6, autosomal dominant gingival fibromatosis 5, and autosomal dominant deafness 27, with the latter linked to disrupted neuronal gene derepression in auditory cells.

REST is classified as SFARI Category 2, indicating a strong candidate gene for autism spectrum disorder (SFARI Cat 2). Given its critical roles in neuronal gene regulation, neural stem cell differentiation, and synaptic development, REST dysfunction may contribute to neurodevelopmental pathology. However, specific mechanistic details of its ASD-related contributions are not detailed in this dataset.

Generated from the curated entity record below. May contain errors — verify against source links.

Genetic Evidence · ASD

SFARI 2

Strong candidate — functional studies support ASD association

Source: SFARI Gene database · gene.sfari.org

Related Publications

Browse all →

Function

Transcriptional repressor which binds neuron-restrictive silencer element (NRSE) and represses neuronal gene transcription in non-neuronal cells (PubMed:11741002, PubMed:11779185, PubMed:12399542, PubMed:26551668, PubMed:7697725, PubMed:7871435, PubMed:8568247). Restricts the expression of neuronal genes by associating with two distinct corepressors, SIN3A and RCOR1, which in turn recruit histone deacetylase to the promoters of REST-regulated genes (PubMed:10449787, PubMed:10734093). Mediates repression by recruiting the BHC complex at RE1/NRSE sites which acts by deacetylating and demethylating specific sites on histones, thereby acting as a chromatin modifier (By similarity). Transcriptional repression by REST-CDYL via the recruitment of histone methyltransferase EHMT2 may be important in transformation suppression (PubMed:19061646). Represses the expression of SRRM4 in non-neural cells to prevent the activation of neural-specific splicing events and to prevent production of REST isoform 3 (By similarity). Repressor activity may be inhibited by forming heterodimers with isoform 3, thereby preventing binding to NRSE or binding to corepressors and leading to derepression of target genes (PubMed:11779185). Also maintains repression of neuronal genes in neural stem cells, and allows transcription and differentiation into neurons by dissociation from RE1/NRSE sites of target genes (By similarity). Thereby is involved in maintaining the quiescent state of adult neural stem cells and preventing premature differentiation into mature neurons (PubMed:21258371). Plays a role in the developmental switch in synaptic NMDA receptor composition during postnatal development, by repressing GRIN2B expression and thereby altering NMDA receptor properties from containing primarily GRIN2B to primarily GRIN2A subunits (By similarity). Acts as a regulator of osteoblast differentiation (By similarity). Key repressor of gene expression in hypoxia; represses genes in hypoxia by direct binding to an RE1/NRSE site on their promoter regions (PubMed:27531581). May also function in stress resistance in the brain during aging; possibly by regulating expression of genes involved in cell death and in the stress response (PubMed:24670762). Repressor of gene expression in the hippocampus after ischemia by directly binding to RE1/NRSE sites and recruiting SIN3A and RCOR1 to promoters of target genes, thereby promoting changes in chromatin modifications and ischemia-induced cell death (By similarity). After ischemia, might play a role in repression of miR-132 expression in hippocampal neurons, thereby leading to neuronal cell death (By similarity). Negatively regulates the expression of SRRM3 in breast cancer cell lines (PubMed:26053433)

Binds to the 3' region of the neuron-restrictive silencer element (NRSE), with lower affinity than full-length REST isoform 1 (By similarity). Exhibits weaker repressor activity compared to isoform 1 (PubMed:11779185). May negatively regulate the repressor activity of isoform 1 by binding to isoform 1, thereby preventing its binding to NRSE and leading to derepression of target genes (PubMed:11779185). However, in another study, does not appear to be implicated in repressor activity of a NRSE motif-containing reporter construct nor in inhibitory activity on the isoform 1 transcriptional repressor activity (PubMed:11741002). Post-transcriptional inactivation of REST by SRRM4-dependent alternative splicing into isoform 3 is required in mechanosensory hair cells in the inner ear for derepression of neuronal genes and hearing (By similarity)

Disease associations

  • Wilms tumor 6WT6

    A pediatric malignancy of kidney, and the most common childhood abdominal malignancy. It is caused by the uncontrolled multiplication of renal stem, stromal, and epithelial cells.

  • Fibromatosis, gingival, 5GINGF5

    An autosomal dominant form of hereditary gingival fibromatosis, a rare condition characterized by a slow, progressive overgrowth of the gingiva. The excess gingival tissue can cover part of or the entire crown, and can result in diastemas, teeth displacement, or retention of primary or impacted teeth.

  • Deafness, autosomal dominant, 27DFNA27

    A form of non-syndromic deafness characterized by postlingual, progressive, moderate to profound sensorineural hearing loss.

Sources

Last updated 5/6/2026, 5:23:55 AM